Yes. Critically, regarding the stability of the funding, and Dr. Pomeroy referred to this, we have different cycles of programs that lead to people having to constantly reinvent themselves. As we develop strategies such as the pan-Canadian AI strategy, the new quantum strategy, and with genomics we have Genome Canada, we need to ensure that the things we invest in have stable, continuous funding.
As I think was hinted at by the previous witnesses, we also need to look at the coordination between programs. While there are great opportunities with having separate funding sources for people, with chairs programs, the operating grants programs, the infrastructure programs through CFI, and then the research support fund, which supports the infrastructure that enables research, it can also be very challenging for researchers because they have to line up all the different funding that often has competitions at different points in time and different windows of what is eligible.
In other countries, there's program funding that enables researchers to get everything they need almost through a one-stop type of process. That's where we need to really think about how we can coordinate all these disparate funding sources in a better way and then focus them on a few of these areas where Canada has the chance to truly lead. As you mentioned, AI, quantum and nanotechnology are some of those areas.